Access to Vaccines Index webinar for investors – co hosted by PRI and ICCR
Wednesday, 31 May 2017
On Wednesday 31 May, the Interfaith Center on Corporate Responsibility (ICCR), the Principles for Responsible Investment (PRI) and the Access to Medicine Foundation, will co-host an investor webinar about the recently published Access to Vaccines Index. Participants will discuss why access to vaccines is a material issue for investors in pharmaceutical companies and how the Access to Vaccines Index can be used as a tool to improve the availability and affordability of vaccines in low- and middle-income countries.
- Jayasree K. Iyer – Executive Director, Access to Medicine Foundation
- Lauren Compere – Managing Director and Director of Shareholder Engagement at Boston Common Asset Management; Board Member, ICCR
- Jon Pender – Vice President, Government Affairs, GSK; and Guy Pickles –Senior Manager, Global Health, GSK Vaccines.
- Hanneke Schuitemaker – Vice President, Head Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines & Prevention (Johnson & Johnson)
The webinar will take place on Wednesday, 31 May at 10:00 EDT/16:00 CEST and will be moderated by Alison Biscoe from PRI. If you have questions for the speakers, you can send them in advance to Alison.Biscoe@unpri.org
You can register for the webinar here.
The Access to Vaccines Index covers:
- 8 companies (Daiichi Sankyo, GSK, Johnson & Johnson, Merck & Co., Inc., Pfizer, Sanofi, Serum Institute of India and Takeda);
- 3 areas of corporate behaviour (research & development; pricing & registration; and manufacturing & supply);
- 69 diseases with the highest priority for improving access to immunisation (including pneumococcal disease, meningococcal disease, seasonal influenza, polio and Ebola).
About the Access to Vaccines Index
The 2017 Access to Vaccines Index will provide an initial baseline of industry activity regarding access to vaccines. It examines where and how companies are already taking action, and brings good practices to the attention of other companies and stakeholders working in the vaccines space. These organisations will be able to use the Index to inform priorities and strategies, and to clarify where new incentives are needed to spur greater positive change. During 2016, the Foundation’s research team will analyse the data captured by the first Access to Vaccines Index, which will be published early in 2017. The Access to Vaccines Index is funded by the Dutch National Postcode Lottery.
About the Access to Medicine Foundation
The Access to Medicine Foundation is an independent, nonprofit organisation based in the Netherlands. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in improving access to medicine. The Foundation is funded by the Bill & Melinda Gates Foundation, the Dutch Ministry of Foreign Affairs and the UK Department for International Development. For ten years, the Foundation has been building consensus on the role for the pharmaceutical industry in improving access to medicine and vaccines. It published its first benchmark of industry activity in this area in 2008, in the first Access to Medicine Index. The fifth Access to Medicine Index was published in November 2016. In 2017, the Foundation published the first Access to Vaccines Index, funded by the Dutch National Postcode Lottery, and will publish the first AntiMicrobial Benchmark, funded by the UK and Dutch governments.